BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 29422597)

  • 1. From genetics to the clinic: a translational perspective on follicular lymphoma.
    Huet S; Sujobert P; Salles G
    Nat Rev Cancer; 2018 Apr; 18(4):224-239. PubMed ID: 29422597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatin modifying gene mutations in follicular lymphoma.
    Green MR
    Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
    van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
    Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
    Kumar E; Pickard L; Okosun J
    Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When to treat patients with relapsed follicular lymphoma.
    Cheah CY; Seymour JF
    Expert Rev Hematol; 2017 Mar; 10(3):187-191. PubMed ID: 28164722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular Lymphoma: Past, Present, and Future.
    Becnel MR; Nastoupil LJ
    Curr Treat Options Oncol; 2018 May; 19(7):32. PubMed ID: 29796824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
    Araujo-Ayala F; Pérez-Galán P; Campo E
    Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature and importance of follicular lymphoma precursors.
    Mamessier E; Broussais-Guillaumot F; Chetaille B; Bouabdallah R; Xerri L; Jaffe ES; Nadel B
    Haematologica; 2014 May; 99(5):802-10. PubMed ID: 24790058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The routes for transformation of follicular lymphoma.
    Okosun J; Montoto S; Fitzgibbon J
    Curr Opin Hematol; 2016 Jul; 23(4):385-91. PubMed ID: 27135979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualized management of follicular lymphoma.
    Bai B; Huang HQ
    Chin Clin Oncol; 2015 Mar; 4(1):7. PubMed ID: 25841714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.
    Green MR; Gentles AJ; Nair RV; Irish JM; Kihira S; Liu CL; Kela I; Hopmans ES; Myklebust JH; Ji H; Plevritis SK; Levy R; Alizadeh AA
    Blood; 2013 Feb; 121(9):1604-11. PubMed ID: 23297126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology, pathogenesis and molecular genetics of follicular NHL.
    Leich E; Ott G; Rosenwald A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of follicular lymphoma transformation.
    Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
    Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future therapeutic approaches for the treatment of follicular lymphoma.
    Pulsoni A; Cappelli LV; Ballotta L; Canichella M; Serrao A; Annechini G; D'Elia GM; Foà R
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):931-941. PubMed ID: 29972084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
    Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
    PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Agents Beyond Immunomodulatory Agents and Phosphoinositide-3-Kinase for Follicular Lymphoma.
    Chin CK; Nastoupil LJ
    Hematol Oncol Clin North Am; 2020 Aug; 34(4):743-756. PubMed ID: 32586578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressors in follicular lymphoma.
    Graham C; LeBrun DP
    Leuk Lymphoma; 2015 Jul; 56(7):1981-8. PubMed ID: 25379618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.